+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Generics Top 5 Emerging Markets Industry Guide 2014-2023

  • ID: 5004305
  • Report
  • February 2020
  • Region: Global
  • 138 pages
  • MarketLine
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Apotex, Inc.
  • Aurobindo Pharma Ltd
  • Cipla Limited
  • EMS SA
  • Eurofarma Laboratorios SA
  • Lupin Ltd
  • MORE
Generics Top 5 Emerging Markets Industry Guide 2014-2023

Summary

The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the emerging five generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights
  • These countries contributed $95,526.6 million to the global generics industry in 2018, with a compound annual growth rate (CAGR) of 9.7% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $126,143.5 million in 2023, with a CAGR of 5.7% over the 2018-23 period.
  • Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $66,912.9 million in 2018. This was followed by India and Mexico with a value of $15,415.2 and $6,337.2 million, respectively.
  • China is expected to lead the generics industry in the top five emerging nations, with a value of $85,292.3 million in 2023, followed by India and Mexico with expected values of $23,288.6 and $8,519.8 million, respectively.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five generics market
  • Leading company profiles reveal details of key generics market players’ emerging five operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the emerging five generics market with five year forecasts by both value and volume
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to buy
  • What was the size of the emerging five generics market by value in 2018?
  • What will be the size of the emerging five generics market in 2023?
  • What factors are affecting the strength of competition in the emerging five generics market?
  • How has the market performed over the last five years?
  • How large is the emerging five generics market in relation to its regional counterparts?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Apotex, Inc.
  • Aurobindo Pharma Ltd
  • Cipla Limited
  • EMS SA
  • Eurofarma Laboratorios SA
  • Lupin Ltd
  • MORE
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 Top 5 Emerging Countries Generics
2.1. Industry Outlook

3 Generics in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
3.7. Country data

4 Generics in Brazil
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators
4.7. Country data

5 Generics in China
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators
5.7. Country data

6 Generics in India
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators
6.7. Country data

7 Generics in Mexico
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
7.6. Macroeconomic Indicators
7.7. Country data

8 Company Profiles
8.1. Aspen Pharmacare Holdings Ltd
8.2. Teva Pharmaceutical Industries Limited
8.3. Adcock Ingram Holdings Ltd
8.4. Pfizer Inc.
8.5. Sanofi SA
8.6. EMS SA
8.7. Ache Laboratorios Farmaceuticos SA
8.8. Eurofarma Laboratorios SA
8.9. Mylan N.V.
8.10. China Grand Pharmaceutical and Healthcare Holdings Limited
8.11. Sun Pharmaceutical Industries Ltd
8.12. Lupin Ltd
8.13. Aurobindo Pharma Ltd
8.14. Cipla Limited
8.15. Apotex, Inc.

Appendix

List of Tables
Table 1: Top 5 emerging countries Generics industry, revenue ($m), 2014-23
Table 2: Top 5 emerging countries Generics industry, revenue ($m), 2014-18
Table 3: Top 5 emerging countries Generics industry forecast, revenue ($m), 2018-23
Table 4: South Africa generics market value: $ million, 2014-18
Table 5: South Africa generics market volume: % of total pharma, 2014-18
Table 6: South Africa generics market geography segmentation: $ million, 2018
Table 7: South Africa generics market value forecast: $ million, 2018-23
Table 8: South Africa generics market volume forecast: % of total pharma, 2018-23
Table 9: South Africa size of population (million), 2014-18
Table 10: South Africa gdp (constant 2005 prices, $ billion), 2014-18
Table 11: South Africa gdp (current prices, $ billion), 2014-18
Table 12: South Africa inflation, 2014-18
Table 13: South Africa consumer price index (absolute), 2014-18
Table 14: South Africa exchange rate, 2014-18
Table 15: Brazil generics market value: $ million, 2014-18
Table 16: Brazil generics market volume: % of total pharma, 2014-18
Table 17: Brazil generics market geography segmentation: $ million, 2018
Table 18: Brazil generics market value forecast: $ million, 2018-23
Table 19: Brazil generics market volume forecast: % of total pharma, 2018-23
Table 20: Brazil size of population (million), 2014-18
Table 21: Brazil gdp (constant 2005 prices, $ billion), 2014-18
Table 22: Brazil gdp (current prices, $ billion), 2014-18
Table 23: Brazil inflation, 2014-18
Table 24: Brazil consumer price index (absolute), 2014-18
Table 25: Brazil exchange rate, 2014-18
Table 26: China generics market value: $ million, 2014-18
Table 27: China generics market volume: % of total pharma, 2014-18
Table 28: China generics market geography segmentation: $ million, 2018
Table 29: China generics market value forecast: $ million, 2018-23
Table 30: China generics market volume forecast: % of total pharma, 2018-23
Table 31: China size of population (million), 2014-18
Table 32: China gdp (constant 2005 prices, $ billion), 2014-18
Table 33: China gdp (current prices, $ billion), 2014-18
Table 34: China inflation, 2014-18
Table 35: China consumer price index (absolute), 2014-18
Table 36: China exchange rate, 2014-18
Table 37: India generics market value: $ million, 2014-18
Table 38: India generics market volume: % of total pharma, 2014-18
Table 39: India generics market geography segmentation: $ million, 2018
Table 40: India generics market value forecast: $ million, 2018-23
Table 41: India generics market volume forecast: % of total pharma, 2018-23
Table 42: India size of population (million), 2014-18
Table 43: India gdp (constant 2005 prices, $ billion), 2014-18
Table 44: India gdp (current prices, $ billion), 2014-18
Table 45: India inflation, 2014-18
Table 46: India consumer price index (absolute), 2014-18
Table 47: India exchange rate, 2014-18
Table 48: Mexico generics market value: $ million, 2014-18
Table 49: Mexico generics market volume: % of total pharma, 2014-18
Table 50: Mexico generics market geography segmentation: $ million, 2018
Table 51: Mexico generics market value forecast: $ million, 2018-23
Table 52: Mexico generics market volume forecast: % of total pharma, 2018-23
Table 53: Mexico size of population (million), 2014-18
Table 54: Mexico gdp (constant 2005 prices, $ billion), 2014-18
Table 55: Mexico gdp (current prices, $ billion), 2014-18
Table 56: Mexico inflation, 2014-18
Table 57: Mexico consumer price index (absolute), 2014-18
Table 58: Mexico exchange rate, 2014-18
Table 59: Aspen Pharmacare Holdings Ltd: key facts
Table 60: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios

List of Figures
Figure 1: Top 5 emerging countries Generics industry, revenue ($m), 2014-23
Figure 2: Top 5 emerging countries Generics industry, revenue ($m), 2014-18
Figure 3: Top 5 emerging countries Generics industry forecast, revenue ($m), 2018-23
Figure 4: South Africa generics market value: $ million, 2014-18
Figure 5: South Africa generics market volume: % of total pharma, 2014-18
Figure 6: South Africa generics market geography segmentation: % share, by value, 2018
Figure 7: South Africa generics market value forecast: $ million, 2018-23
Figure 8: South Africa generics market volume forecast: % of total pharma, 2018-23
Figure 9: Forces driving competition in the generics market in South Africa, 2018
Figure 10: Drivers of buyer power in the generics market in South Africa, 2018
Figure 11: Drivers of supplier power in the generics market in South Africa, 2018
Figure 12: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2018
Figure 13: Factors influencing the threat of substitutes in the generics market in South Africa, 2018
Figure 14: Drivers of degree of rivalry in the generics market in South Africa, 2018
Figure 15: Brazil generics market value: $ million, 2014-18
Figure 16: Brazil generics market volume: % of total pharma, 2014-18
Figure 17: Brazil generics market geography segmentation: % share, by value, 2018
Figure 18: Brazil generics market value forecast: $ million, 2018-23
Figure 19: Brazil generics market volume forecast: % of total pharma, 2018-23
Figure 20: Forces driving competition in the generics market in Brazil, 2018
Figure 21: Drivers of buyer power in the generics market in Brazil, 2018
Figure 22: Drivers of supplier power in the generics market in Brazil, 2018
Figure 23: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2018
Figure 24: Factors influencing the threat of substitutes in the generics market in Brazil, 2018
Figure 25: Drivers of degree of rivalry in the generics market in Brazil, 2018
Figure 26: China generics market value: $ million, 2014-18
Figure 27: China generics market volume: % of total pharma, 2014-18
Figure 28: China generics market geography segmentation: % share, by value, 2018
Figure 29: China generics market value forecast: $ million, 2018-23
Figure 30: China generics market volume forecast: % of total pharma, 2018-23
Figure 31: Forces driving competition in the generics market in China, 2018
Figure 32: Drivers of buyer power in the generics market in China, 2018
Figure 33: Drivers of supplier power in the generics market in China, 2018
Figure 34: Factors influencing the likelihood of new entrants in the generics market in China, 2018
Figure 35: Factors influencing the threat of substitutes in the generics market in China, 2018
Figure 36: Drivers of degree of rivalry in the generics market in China, 2018
Figure 37: India generics market value: $ million, 2014-18
Figure 38: India generics market volume: % of total pharma, 2014-18
Figure 39: India generics market geography segmentation: % share, by value, 2018
Figure 40: India generics market value forecast: $ million, 2018-23
Figure 41: India generics market volume forecast: % of total pharma, 2018-23
Figure 42: Forces driving competition in the generics market in India, 2018
Figure 43: Drivers of buyer power in the generics market in India, 2018
Figure 44: Drivers of supplier power in the generics market in India, 2018
Figure 45: Factors influencing the likelihood of new entrants in the generics market in India, 2018
Figure 46: Factors influencing the threat of substitutes in the generics market in India, 2018
Figure 47: Drivers of degree of rivalry in the generics market in India, 2018
Figure 48: Mexico generics market value: $ million, 2014-18
Figure 49: Mexico generics market volume: % of total pharma, 2014-18
Figure 50: Mexico generics market geography segmentation: % share, by value, 2018
Figure 51: Mexico generics market value forecast: $ million, 2018-23
Figure 52: Mexico generics market volume forecast: % of total pharma, 2018-23
Figure 53: Forces driving competition in the generics market in Mexico, 2018
Figure 54: Drivers of buyer power in the generics market in Mexico, 2018
Figure 55: Drivers of supplier power in the generics market in Mexico, 2018
Figure 56: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2018
Figure 57: Factors influencing the threat of substitutes in the generics market in Mexico, 2018
Figure 58: Drivers of degree of rivalry in the generics market in Mexico, 2018
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Aspen Pharmacare Holdings Ltd
  • Teva Pharmaceutical Industries Limited
  • Adcock Ingram Holdings Ltd
  • Pfizer Inc.
  • Sanofi SA
  • EMS SA
  • Ache Laboratorios Farmaceuticos SA
  • Eurofarma Laboratorios SA
  • Mylan N.V.
  • China Grand Pharmaceutical and Healthcare Holdings Limited
  • Sun Pharmaceutical Industries Ltd
  • Lupin Ltd
  • Aurobindo Pharma Ltd
  • Cipla Limited
  • Apotex, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll